
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Steven A Kaplan, MD
Urology
About Me
Dr. Steven Kaplan is Director of the Men's Wellness Program, Mount Sinai Health System and Professor, Icahn School of Medicine at Mount Sinai. He is an internationally renowned authority and one of the primary thought leaders in the study of benigh diseases, the association of metabolic factors with voiding dysfunction, and female urology, with symptoms related to both benign prostate enlargement and bladder function.
Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is an internationally recognized authority and one of the primary thought leaders in the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction and female urology. He has over 1000 publications including 600 peer reviewed and 570 peer reviewed invited articles, and 90 book chapters and non – peered reviewed articles. His landmark study, published in JAMA in 2006, changed the way medications are used in the treatment of men with symptoms related to both benign prostate enlargement and bladder dysfunction. He has made over 340 presentations in more than 35 countries. He is the co - author of five books and is on the Editorial Board of numerous journals including Urology, Journal of Urology, and Urology Times.
Dr. Kaplan is a member of more than 30 professional organizations, been awarded 5 NIH grants and has received over 13 million dollars in research funding. He serves as both member and / or Chair of numerous study sections for the NIH and more recently, he chaired the NIDDK Prostate Strategic Planning Committee and currently Chairs the AUA Research Committee on Advocacy. He also has served on the American Urologic Association Guidelines Panel for BPH. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.
Dr. Kaplan joined Mount Sinai from Weill Cornell Medical College, where he held the tenured position of E. Darracott Vaughan, Jr. Professor of Urology as well as Director of the Iris Cantor Men’s Health Center. In that position, he was responsible for the development of a new discipline within Urology, Integrated Men’s Health. Over his tenure at Weill Cornell Medical College, he was actively engaged with teaching and supervising both residents and fellows and was the Director of the Fellowship Program in Male and Female Voiding Dysfunction. Prior to this, he held the tenured position of Given Foundation Professor of Urology at Columbia University and was the Vice Chairman and Program Director.
Dr. Kaplan graduated from Mount Sinai School of Medicine in 1982 and was elected to the AOA Honor Society. Dr. Kaplan’s postgraduate training included an internship and residency in the Department of Surgery at Mount Sinai Hospital as well as a residency in Urology at the Squier Urologic Clinic, Columbia University. He was an American Urologic Association Scholar between 1988 - 1990 that focused on identifying molecular markers and urodynamic parameters that herald bladder and prostate dysfunction.
Language
English, Hebrew, Yiddish
Position
PROFESSOR | Urology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Chronic Pain
- Chronic Pelvic Pain
- Chronic Prostatitis
- Congenital Kidney Disease
- Cystoscopy
- Diets, Food, and Nutrients
- Frequent Urination
- Hydrocele/Varicocele
- Hydronephrosis
- Impotence
- Incontinence Surgery
- Lower Urinary Tract Symptoms
- Neurogenic Bladder
- Prostate Cancer
- Prostate Cancer Screening
- Prostate-Specific Antigen (PSA) Test
- Prostatectomy
- Urinary Tract Infection
- Urinary Urgency
- Wellness
Education
BS, CUNY Brooklyn College
MD, Icahn School of Medicine at Mount Sinai
MD, Mount Siinai School of Medicine
Residency, Surgery (General Surgery)
Mount Sinai Hospital
Residency, Urology
Columbia University Medical Center-Psychiatry GME
Fellowship, Urology
Columbia University Medical Center-Psychiatry GME
Certifications
American Board of Urology
Awards
2008
New York Top Doctors
Castle Connollly/New York Magazine
2003
John K. Lattimer Urology Lifetime Award
Kidney and Urology Foundation
1997
New York Best Doctors
Castle Connolly/New York Magazine
1997
Best Doctors in America
Castle Connolly
Research
The focus of my research initiatives was in enhancing our understanding of the role of various therapies in treating men and women with voiding dysfunction. More specifically, the role of various medical and minimally invasive therapies for benign prostatic hyperplasia (BPH) was at the core my NIH and clinical grants. Through these endeavors, the landscape of BPH therapy has changed dramatically over the past 15 years. Moreover, the role of early intervention, progression of disease and predictive outcomes have served as templates for current thought. The value of combination therapy for many men based on prostate size and symptom profile is now the standard throughout the world.
In addition, in my role as fellowship director for the past 20 years, I have helped foster an environment of discovery with many of my fellows working in collaboration and creating scientific impact. More recently, my research has focused on clinical outcomes and economic modeling in various aspects of urologic care and more specifically, Men’s Health. The role of diabetes, cardiovascular disease and aging on pelvic health emanated from work done with other groups such as the Boston Area Community Health Survey.
At Mount Sinai, my goal is to help build a clinical research infrastructure that will use digital informatics with enhanced uploading of epidemiologic and clinical data among the various entry points in the Men’s Health Network to be created throughout Manhattan. Longitudinal and dynamic monitoring will allow for the development of predictive treatment algorithms and enhance quality of care and outcomes.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Oxford Care
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Kaplan during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Board Service
- Zetia Health
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Tilray Brands
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Aspargo Labs
Founder/Co-Founder/Partner
- Zetia Health
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.